※ Cumulative through Sep 22, 2026, vs. same period last year
ORTHOMOL PHARMAZEUTISCHE VERTRIEBS GMBH shipped 30 cases to Korea in 2026, up 3% from the same period last year (29 cases). Main origins: Germany.
Top exported products: ORTHOMOL IMMUN 6 cases (up 200%), ORTHOMOL VITAL M 3 cases (no same-period record last year · last Jan 2026, 1 cases total), ORTHOMOL VITAL F 2 cases (unchanged).
Top importers: Donga Pharm. Co., Ltd. 30 cases (up 3%).
Top trading importer: Donga Pharm. Co., Ltd. accounts for 100.0% of all recorded cases in the stated period.
| Product | Shipments | vs. last year |
|---|---|---|
| ORTHOMOL IMMUN | 6 | ▲ +200% |
| ORTHOMOL VITAL M | 3 | New |
| ORTHOMOL VITAL F | 2 | Unchanged |
| ORTHOMOL IMMUN | 2 | ▲ +100% |
| ORTHOMOL VITAL M | 2 | New |
| Importer | Shipments | vs. last year |
|---|---|---|
| Donga Pharm. Co., Ltd. | 30 | ▲ +3% |
| Country | Shipments | vs. last year |
|---|---|---|
| Germany | 30 | — |
Source: Ministry of Food and Drug Safety import records, compiled by TAAMs. Current period: 2026-05-01 ~ 2026-09-22; prior-year comparison: 2025-05-01 ~ 2025-09-22. Counts are source-record rows, not transaction value or contract counts.